טוען...
Myeloid‐derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
Myeloid‐derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells that accumulate during pathologic conditions, such as cancer. Patients diagnosed with advanced metastatic cancers have an average survival of 12–24 mo, a survival time that hasn't changed significa...
שמור ב:
| הוצא לאור ב: | J Leukoc Biol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Society for Leukocyte Biology
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6608049/ https://ncbi.nlm.nih.gov/pubmed/28546500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.5VMR1116-458RRR |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|